HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Clinical trials for HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for deadly Post-Transplant blood disorder
Disease control Not yet recruitingThis study tests a new pill, iptacopan, for a rare but serious blood vessel condition called TA-TMA that can happen after a stem cell transplant. The drug aims to block harmful immune system activity and protect blood vessels. About 30 people who have not responded to initial tre…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated May 17, 2026 09:03 UTC
-
Prehab before transplant: a new hope for stronger recovery
Disease control Not yet recruitingThis study tests whether a personalized program of exercise, education, and support before a stem cell transplant can improve strength, reduce frailty, and boost quality of life in adults with blood cancer. About 68 participants will be randomly assigned to either the prehabilita…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Phase: NA • Sponsor: Hospital del Salvador • Aim: Disease control
Last updated May 15, 2026 11:53 UTC